VANCOUVER, Aug. 6, 2019 /PRNewswire/ - Choom™ (CSE: CHOO; OTCQB: CHOOF), an emerging adult use cannabis company that has secured one of the largest national retail networks in Canada, is pleased to announce that it has signed a definitive agreement to acquire The Green Room, a popular cannabis retail store chain which has opera

CRANBURY, N.J., Aug. 6, 2019 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) announced today that it will be presenting at Canaccord Genuity's 39th Annual Growth Conference on Wednesday, August 7, 2019, at 10:30 am ET.  The conference will be held at the InterContinental

OLDWICK, N.J., Aug. 6, 2019 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today reported financial results for the second quarter ended June 30, 2019 and provided a business update."The data from the NIH-Sponsored 'At Risk' study, whi

LAVAL, Quebec, Aug. 6, 2019 /PRNewswire/ --Second-Quarter 2019 Financial Results Revenues of $2.152 Billion GAAP Net Loss of $171 Million

DUBLIN, Aug. 6, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today reported its second quarter 2019 financial results including GAAP net revenues of $4.09 billion, a 0.8 percent decrease from the prior year quarter. Excluding foreign exchange impact, second quarter 2019 non-GAAP net revenues increased 1.2 per

CAMBRIDGE, Mass., Aug. 6, 2019 /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ: LPTX) today announced that its anti-Dickkopf-1 (DKK1) antibody, DKN-01, in combination with Merck's anti-PD-1 antibody, Keytruda® (pembrolizumab), demonstrated higher survival and objective response outcomes in patients with advanced ga

TEL AVIV, Israel, Aug. 6, 2019 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology, today reports its financial results for the quarter ended June 30, 2019 and provides a corporate update.Highlights and achievements during the second quarter 2019 and subsequent period:

4Front to receive lump-sum settlement with respect to one of its historical revenue-share contracts VANCOUVER, British Columbia and PHOENIX, Aug. 6, 2019 /PRNewswire/ -- 4Front Ventures Corp. (CSE: FFNT) ("4Front") today debuts on the Canadian Securities Exchange ("CSE") under the ticker symbol "FFNT

ALBANY, N.Y., Aug. 6, 2019 /PRNewswire/ -- Healthy Alliance Independent Practice Association (IPA) and MVP Health Care today announced a groundbreaking partnership that will provide funding to community based organizations (CBOs) in the Capital Region. Approximately $800,000 will be distributed to a select group of non-profits whose ser

NASHVILLE, Tenn., Aug. 6, 2019 /PRNewswire/ -- Verdi Oncology, Inc., an oncology practice and clinical research management company, announced today it has launched Verdi Cancer and Research Center of Texas. The center, led by Dr. Jivesh Sharma and Dr. Amy Cripps, will provide high quality medical oncology ca